Research Work Participated in Phase II clinical trials of three drugs, as well as projects funded by the National Eleventh Five-Year Plan, National Twelfth Five-Year Plan, Beijing Natural Science Foundation, and Beijing Municipal Science and Technology Commission. The project content primarily focuses on clinical application research of traditional Chinese medicine, including clinical studies on the treatment of liver failure, hepatocellular carcinoma, and liver fibrosis with traditional Chinese medicine, as well as research on the inheritance of renowned veteran Chinese medicine practitioners. Major research work in the past five years mainly includes: 1. Principal Investigator of a sub-center project under the National Thirteenth Five-Year Plan Major Special Project: Clinical study on Huqi Formula based on the combination of disease-syndrome-sign in the treatment of stage III hepatitis B-related hepatocellular carcinoma 2. Principal Investigator of a Beijing Municipal Administration of Traditional Chinese Medicine project: A randomized controlled clinical study on the effect of Dihuang Yinzi on reaction ability in minimal hepatic encephalopathy 3. Participant in a Beijing Natural Science Foundation project: Exploring the effect and molecular mechanism of Tanshinone IIA on hepatocellular carcinoma metastasis based on Sulfatase 2 4. Participant in the National Twelfth Five-Year Plan supporting project: Research on the clinical experience and academic thought inheritance of renowned veteran Chinese medicine practitioners Awards In 2018, the Beijing Municipal Administration of Traditional Chinese Medicine project was awarded the title of "Demonstration Project." Publications and Translations Published over 10 research and teaching papers, including "Clinical efficacy analysis of Dihuang Yinzi in the treatment of minimal hepatic encephalopathy," "Analysis of Professor Qian Ying's experience in the syndrome differentiation and treatment of primary hepatocellular carcinoma," "Clinical efficacy analysis of Huqi Formula in the treatment of advanced primary hepatocellular carcinoma," and several other papers. Participated in the partial writing of "Standardization of Effective Prescriptions Inheritance – Demonstration Application."